AstraZeneca Pharma India Limited (BOM:506820)

AstraZeneca Pharma India Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 9, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	230,915	215,159	133,010	81,183	63,886	75,255
Market Cap Growth	36.91%	61.76%	63.84%	27.07%	-15.11%	25.87%
Enterprise Value	225,911	210,362	127,861	76,552	60,484	72,857
Last Close Price	9236.60	8577.01	5284.39	3211.62	2520.50	2967.13
PE Ratio	125.96	185.90	82.35	81.76	103.71	80.66
PS Ratio	12.45	12.54	10.27	8.09	7.93	9.25
PB Ratio	29.98	27.93	18.68	13.79	12.49	16.50
P/TBV Ratio	30.00	27.95	18.74	13.79	12.49	16.50
P/FCF Ratio	-	338.25	777.38	163.12	70.07	77.53
P/OCF Ratio	-	329.19	477.25	139.27	63.38	71.82
EV/Sales Ratio	12.18	12.26	9.87	7.63	7.51	8.96
EV/EBITDA Ratio	78.11	84.67	69.81	47.45	73.16	54.94
EV/EBIT Ratio	92.14	97.93	74.58	51.43	87.20	62.67
EV/FCF Ratio	-	330.71	747.29	153.81	66.33	75.06
Debt / Equity Ratio	0.05	0.05	0.01	0.01	0.02	0.03
Debt / EBITDA Ratio	0.12	0.14	0.02	0.04	0.10	0.09
Debt / FCF Ratio	-	0.56	0.27	0.14	0.10	0.13
Asset Turnover	-	1.32	1.26	1.09	0.99	1.10
Inventory Turnover	-	2.50	2.87	2.22	2.11	1.85
Quick Ratio	-	1.05	1.89	1.61	1.64	1.46
Current Ratio	-	1.91	2.61	2.18	2.12	2.04
Return on Equity (ROE)	-	15.62%	24.84%	18.05%	12.73%	22.74%
Return on Assets (ROA)	-	10.34%	10.39%	10.11%	5.32%	9.81%
Return on Capital (ROIC)	20.13%	17.64%	16.33%	16.67%	8.77%	17.21%
Return on Capital Employed (ROCE)	-	26.40%	23.80%	24.80%	13.20%	24.70%
Earnings Yield	0.79%	0.54%	1.21%	1.22%	0.96%	1.24%
FCF Yield	-	0.30%	0.13%	0.61%	1.43%	1.29%
Dividend Yield	0.35%	0.37%	0.45%	0.50%	0.40%	0.07%
Payout Ratio	-	51.84%	24.77%	20.14%	8.12%	5.36%
Total Shareholder Return	0.30%	0.37%	0.45%	0.50%	0.40%	0.07%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.